Document is current
Any future updates will be listed below
-
Authors
Shi, Yixing https://orcid.org/0009-0000-9411-0080
Sun, Qianqian
Jia, Fuchuan
Xie, Xiangyu
Zhou, Xiangyu
Guo, Rong
Zeng, Yangfan
Chen, Shanshan
Guo, Zhenzhen
Sun, Wenli
Guo, Tong
Xia, Yu
Li, Wenlong
Zhang, Li https://orcid.org/0000-0002-0698-0754
- License Information
-
More Information
Article History
Received: 19 February 2024
Accepted: 4 April 2025
First Online: 14 May 2025
Competing interests
: Y.Y., W. Shi, Y.S., Q.S., F.J. and X.X. have three pending patent applications related to the following aspects: (1) the MN1-BEND2 KI mouse model; (2) the MN1-BEND2 KI cell model; and (3) the therapeutic use of crenolanib and CP-673451 for treating ABM. These patents encompass methodologies for developing ABM mouse and iNPC models, as well as the use of crenolanib and CP-673451 as a therapeutic against this disease. The authors declare no other competing interests.
